BRNS Barinthus Biotherapeutics plc
$0.74▼ -2.49%
Healthcare
Other
Volume 376.1K
Avg Volume (10D) 126.1K
Key Metrics & Fundamentals
Market Cap
$30.23M
P/E Ratio
–
Div Yield
–%
52W Range
0.51 - 1.83
% vs 50 MA
16.98%
% vs 200 MA
12.38%
RSI-14
60.2
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.88
Free Cash Flow
-$8.09M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$9.79M
COGS
–
Operating Exp
$10.98M
Operating Income
-$10.98M
EBIT
-$10.98M
Pretax Income
-$10.62M
Net Income
-$10.58M
EPS (Diluted)
-0.26
Price & Volume History
Loading chart…
Recent News
Is Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Stock Outpacing Its Medical Peers This Year?
Zacks · Sep 7, 2026 1:40 PM
Barinthus Bio Provides Update on Proposed Combination with Clywedog Therapeutics
GlobeNewswire · Aug 24, 2026 10:57 PM
Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments
GlobeNewswire · Aug 6, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BRNS's money flow as a full page
Social Sentiment
No Reddit posts found for BRNS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.